4-imidazolyl-1,2,3,4-tetrahydroquinoline derivatives and their use as aldosterone/11-beta-hydroxylase inhibitors

Details for Australian Patent Application No. 2007333902 (hide)

Owner Novartis AG

Inventors Hu, Qi-Ying; Ksander, Gary Michael

Agent Davies Collison Cave

Pub. Number AU-A-2007333902

PCT Pub. Number WO2008/076860

Priority 60/870,497 18.12.06 US

Filing date 14 December 2007

Wipo publication date 26 June 2008

International Classifications

C07D 401/02 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

2 July 2009 PCT application entered the National Phase

  PCT publication WO2008/076860 Priority application(s): WO2008/076860

5 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007333904-1-substituted imidazole derivatives and their use as aldosterone synthase inhibitors

2007333895-Cardiac device and methods of use thereof